Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Emidio Scarpellini

Showing results (11-20 of 75) with videos related to

Pageof 8
Sort By:
Nature Reviews. Gastroenterology & Hepatology|April 15, 2016
Management of refractory typical GERD symptomsEmidio Scarpellini, Daphne Ang, Ans Pauwels, et al.
Minerva Gastroenterology|January 18, 2022
Probiotics and obesity associated disease: an extended view beyond traditional strainsTetyana Falalyeyeva, Yelyzaveta Mamula, Emidio Scarpellini, et al.
Biomedicines|August 29, 2024
Gut Microbiota, Deranged Immunity, and Hepatocellular CarcinomaEmidio Scarpellini, Giuseppe Guido Maria Scarlata, Valeria Santori, et al.
Medicina (Kaunas, Lithuania)|November 25, 2023
Ultrasound Prevalence and Clinical Features of Nonalcoholic Fatty Liver Disease in Patients with Inflammatory Bowel Diseases: A Real-Life Cross-Sectional StudyLudovico Abenavoli, Rocco Spagnuolo, Giuseppe Guido Maria Scarlata, et al.
Reviews on Recent Clinical Trials|September 17, 2020
Tocilizumab in SARS-CoV-2 Patients with the Syndrome of Cytokine Storm: A Narrative ReviewShanmugaraj Kulanthaivel, Vitalii B Kaliberdenko, Keerthanaa Balasundaram, et al.
Digestive Diseases (Basel, Switzerland)|September 11, 2007
Small intestinal bacterial overgrowth: diagnosis and treatmentAntonio Gasbarrini, Ernesto Cristiano Lauritano, Maurizio Gabrielli, et al.
Internal and Emergency Medicine|September 25, 2010
Gut microbiota and obesityEmidio Scarpellini, Mariachiara Campanale, Diana Leone, et al.
Reviews on Recent Clinical Trials|August 13, 2016
Gut Microbiota and Alcoholic Liver DiseaseEmidio Scarpellini, Mariana Forlino, Marinella Lupo, et al.
Medicina (Kaunas, Lithuania)|March 27, 2025
The Management of Cardiometabolic Risk in MAFLD: Therapeutic Strategies to Modulate Deranged Metabolism and Cholesterol LevelsAnnalisa Pezzoli, Ludovico Abenavoli, Marialaura Scarcella, et al.
Nutrients|December 23, 2022
Gut Microbiota in Non-Alcoholic Fatty Liver Disease Patients with Inflammatory Bowel Diseases: A Complex InterplayLudovico Abenavoli, Lidia Giubilei, Anna Caterina Procopio, et al.
Pageof 8

Showing results (11-20 of 75) with videos related to

Sort By:
Pageof 8
Nature Reviews. Gastroenterology & Hepatology|April 15, 2016
Management of refractory typical GERD symptomsEmidio Scarpellini, Daphne Ang, Ans Pauwels, et al.
Minerva Gastroenterology|January 18, 2022
Probiotics and obesity associated disease: an extended view beyond traditional strainsTetyana Falalyeyeva, Yelyzaveta Mamula, Emidio Scarpellini, et al.
Biomedicines|August 29, 2024
Gut Microbiota, Deranged Immunity, and Hepatocellular CarcinomaEmidio Scarpellini, Giuseppe Guido Maria Scarlata, Valeria Santori, et al.
Medicina (Kaunas, Lithuania)|November 25, 2023
Ultrasound Prevalence and Clinical Features of Nonalcoholic Fatty Liver Disease in Patients with Inflammatory Bowel Diseases: A Real-Life Cross-Sectional StudyLudovico Abenavoli, Rocco Spagnuolo, Giuseppe Guido Maria Scarlata, et al.
Reviews on Recent Clinical Trials|September 17, 2020
Tocilizumab in SARS-CoV-2 Patients with the Syndrome of Cytokine Storm: A Narrative ReviewShanmugaraj Kulanthaivel, Vitalii B Kaliberdenko, Keerthanaa Balasundaram, et al.
Digestive Diseases (Basel, Switzerland)|September 11, 2007
Small intestinal bacterial overgrowth: diagnosis and treatmentAntonio Gasbarrini, Ernesto Cristiano Lauritano, Maurizio Gabrielli, et al.
Internal and Emergency Medicine|September 25, 2010
Gut microbiota and obesityEmidio Scarpellini, Mariachiara Campanale, Diana Leone, et al.
Reviews on Recent Clinical Trials|August 13, 2016
Gut Microbiota and Alcoholic Liver DiseaseEmidio Scarpellini, Mariana Forlino, Marinella Lupo, et al.
Medicina (Kaunas, Lithuania)|March 27, 2025
The Management of Cardiometabolic Risk in MAFLD: Therapeutic Strategies to Modulate Deranged Metabolism and Cholesterol LevelsAnnalisa Pezzoli, Ludovico Abenavoli, Marialaura Scarcella, et al.
Nutrients|December 23, 2022
Gut Microbiota in Non-Alcoholic Fatty Liver Disease Patients with Inflammatory Bowel Diseases: A Complex InterplayLudovico Abenavoli, Lidia Giubilei, Anna Caterina Procopio, et al.
Pageof 8